|
|
|
|
|
|
Vascular Biogen. Ord (VBLT)
|
|
4.90 +0.05 (+1.03%)
|
6/23/2017 4:00pm
|
|
Open:
|
4.90
|
Pre. Close:
|
4.85
|
|
High:
|
4.95
|
Low:
|
4.85
|
|
Volume:
|
50,693
|
Market Cap:
|
131.84M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
5.01 - 5.17
|
5.17 - 5.37
|
|
Low:
|
4.65 - 4.72
|
4.72 - 4.8
|
|
Close:
|
4.76 - 4.92
|
4.92 - 5.13
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-23 4:39:18 PM)
|
|
Overall:
|
|
|
Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.
|
|
Target:
|
Six months: 6.39  One year: 7.09
|
|
Support:
|
Support1: 4.50 Support2: 3.74
|
|
Resistance:
|
Resistance1:
5.47 Resistance2: 6.07
|
|
Pivot:
|
4.98
|
|
Moving Averages:
|
MA(5): 4.93  MA(20): 5.13
MA(100): 5.56 MA(250): 5.02
|
|
MACD:
|
MACD(12,26):
-0.23 Signal(12,26,9): -0.23
|
|
%K %D:
|
%K(14,3): 34.78 %D(3): 36.64
|
|
RSI:
|
RSI(14): 40.82
|
|
52-Week:
|
High: 6.70
Low: 3.74 Change(%): 16.4
|
|
Average Vol(K):
|
3-Month: 93
10-Days 104
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.VBLT has closed above bottom band by 43.3%. Bollinger Bands are 33.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Tue, 23 May 2017 23:45:58 GMT
Vascular Biogenics (VBLT) Earning Favorable Press Coverage, Analysis Finds
Thu, 02 Oct 2014 20:04:30 GMT
4.90
Mon, 15 May 2017 15:45:00 GMT
Vascular Biogenics' (VBLT) CEO Dror Harats on Q1 2017 Results - Earnings Call ...
Wed, 01 Oct 2014 09:20:07 GMT
News Vascular Biogenics Ltd.VBLT
Tue, 03 Nov 2015 14:21:57 GMT
Vascular Biogenics Ltd. Announces Pricing of $15 Million Underwritten Offering ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
